Zobrazeno 1 - 10
of 710
pro vyhledávání: '"Kiese B"'
Autor:
Heinrich MC; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Corless CL; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Demetri GD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Blanke CD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., von Mehren M; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Joensuu H; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., McGreevey LS; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Chen CJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Van den Abbeele AD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Druker BJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Kiese B; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Eisenberg B; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Roberts PJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Singer S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Fletcher CDM; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Silberman S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Dimitrijevic S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Fletcher JA; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Nov 01; Vol. 41 (31), pp. 4829-4836.
Autor:
Ablikim, and Achasov, M., and Ahmed, M. N., and Ai, S., and Albrecht, X. C., and Ambrose, M., and Amoroso, D. J., and An, A., and An, F. F., and Bai, Q., and Bakina, J. Z., and Ferroli, O., Baldini and Ban, R., and Bennett, Y., and Bennett, D. W., and Berger, J. V., and Bertani, N., and Bettoni, M., and Bian, D., and Bianchi, J. M., and Boger, F., and Boyko, E., and Briere, I., and Cai, R. A., and Cai, H., and Cakir, X., and Calcaterra, O., and Cao, A., and Cetin, G. F., and Chai, S. A., and Chang, J., and Chelkov, J. F., and Chen, G., and Chen, H. S., and Chen, J. C., and Chen, M. L., and Chen, P. L., and Chen, S. J., and Chen, X. R., and Chu, Y. B., and Cibinetto, X. K., and Dai, G., and Dai, H. L., and Dbeyssi, J. P., and Dedovich, A., and Deng, D., and Denig, Z. Y., and Denysenko, A., and Destefanis, I., and De Mori, M., and Ding, F., and Dong, Y., and Dong, C., and Dong, J., and Dong, L. Y., and Dou, M. Y., and Du, Z. L., and Duan, S. X., and Fang, P. F., and Fang, J., and Fang, S. S., and Farinelli, Y., and Fava, R., and Fegan, L., and Feldbauer, S., and Felici, F., and Feng, G., and Fioravanti, C. Q., and Fritsch, E., and Fu, M., and Gao, C. D., and Gao, Q., and Gao, X. L., and Gao, Y., and Garzia, Z., and Goetzen, I., and Gong, K., and Gong, L., and Gradl, W. X., and Greco, W., and Gu, M., and Gu, M. H., and Guo, Y. T., and Guo, A. Q., and Guo, R. P., and Haddadi, Y. P., and Han, Z., and Hao, S., and Harris, X. Q., and He, F. A., and He, K. L., and Heinsius, X. Q., and Held, F. H., and Heng, T., and Holtmann, Y. K., and Hou, T., and Hu, Z. L., and Hu, H. M., and Hu, T., and Huang, Y., and Huang, G. S., and Huang, J. S., and Huang, X. T., and Huang, X. Z., and Hussain, Z. L., and Andersson, T., Ikegami and Ji, W., and Ji, Q., and Ji, Q. P., and Ji, X. B., and Jiang, X. L., and Jiang, L. W., and Jiang, X. S., and Jiao, X. Y., and Jiao, J. B., and Jie, Z., and Jin, Q. L., and Jin, D. P., and Johansson, S., and Julin, T., and Kalantar-Nayestanaki, A., and Kang, N., and Kang, X. L., and Kavatsyuk, X. S., and Ke, M., and Kiese, B. C., and Kliemt, P., and Kloss, R., and Kolcu, B., and Kopf, O. B., and Kornicer, B., and Kupsc, M., Pacetti, S.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3982::95071ee5e0d8aaff138d41b1bb0b2b37
http://hdl.handle.net/11391/1462875
http://hdl.handle.net/11391/1462875
Autor:
Ganzon, Rebecca1 (AUTHOR), Chen, Wei2 (AUTHOR), Tinoco, Gabriel1 (AUTHOR) gabriel.tinoco@osumc.edu, Mayordomo, Jose I. (AUTHOR) josemayordomo@hotmail.com
Publikováno v:
Case Reports in Oncological Medicine. 8/5/2024, Vol. 2024, p1-6. 6p.
Autor:
Nguyen-Thi PT; Faculty of Pharmacy, HUTECH University, Ho Chi Minh City, 700000, Vietnam., Vo TK; Department of Sports Medicine, University of Medicine and Pharmacy (VNU-UMP), Vietnam National University Hanoi, Hanoi, 100000, Vietnam., Le HT; Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City, 700000, Vietnam., Nguyen NTT; Faculty of Chemical Engineering, Industrial University of Ho Chi Minh City, Ho Chi Minh City, 71420, Vietnam. nguyenthinhatthang@iuh.edu.vn., Nguyen TT; Faculty of Chemical Engineering, Industrial University of Ho Chi Minh City, Ho Chi Minh City, 71420, Vietnam., Van Vo G; Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA. gvo@sbpdiscovery.org.
Publikováno v:
Pharmaceutical research [Pharm Res] 2024 Jun; Vol. 41 (6), pp. 1045-1092. Date of Electronic Publication: 2024 Jun 11.
Autor:
Brouwer, RE, Vellenga, E, Zwinderman, KH, Bezwoda, WR, Durrant, STS, Herrmann, RP, Kiese, B, Maraninchi, D, Milligan, DW, Sklenar, [No Value], Tabilio, A, Volonte, JLP, Winfield, DA, Fibbe, WE
Publikováno v:
British Journal of Haematology, 106(3), 730-736. Wiley
We evaluated the efficacy of recombinant human interleukin-3 (rhIL-3) in reducing the number of platelet transfusions and major infections after autologous bone marrow transplantation (ABMT) in patients with malignant lymphoma. 198 patients with non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::2e6e38f3734d5b8d509c2fc6e0821825
https://research.rug.nl/en/publications/a2630ada-1adf-46bf-8b28-7a7c2e535eac
https://research.rug.nl/en/publications/a2630ada-1adf-46bf-8b28-7a7c2e535eac
Autor:
Seefried L; Orthopedic Center of Musculoskeletal Research, Orthopedic Department, University of Würzburg, Würzburg, Germany., Baumann J; Orthopedic Center of Musculoskeletal Research, Orthopedic Department, University of Würzburg, Würzburg, Germany., Hemsley S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Hofmann C; Children's Hospital and., Kunstmann E; Institute for Human Genetics, University of Würzburg, Würzburg, Germany., Kiese B; Novartis Pharma AG, Basel, Switzerland., Huang Y; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Chivers S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Valentin MA; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Borah B; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts, USA., Roubenoff R; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Junker U; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Jakob F; Orthopedic Center of Musculoskeletal Research, Orthopedic Department, University of Würzburg, Würzburg, Germany.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2017 Jun 01; Vol. 127 (6), pp. 2148-2158. Date of Electronic Publication: 2017 Apr 24.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Voicu, Victor1,2 (AUTHOR) victor.voicu@yahoo.com, Brehar, Felix-Mircea3,4 (AUTHOR) felixbrehar@yahoo.com, Toader, Corneliu4,5 (AUTHOR) antonio.corlatescu0920@stud.umfcd.ro, Covache-Busuioc, Razvan-Adrian4 (AUTHOR) andrei.bordeianu@stud.umfcd.ro, Corlatescu, Antonio Daniel4 (AUTHOR) horia-petre.costin0720@stud.umfcd.ro, Bordeianu, Andrei4 (AUTHOR) bogdan.bratu@stud.umfcd.ro, Costin, Horia Petre4 (AUTHOR) luca-andrei.glavan0720@stud.umfcd.ro, Bratu, Bogdan-Gabriel4 (AUTHOR) prof.avciurea@gmail.com, Glavan, Luca-Andrei4 (AUTHOR), Ciurea, Alexandru Vlad4,6 (AUTHOR)
Publikováno v:
Biomolecules (2218-273X). Sep2023, Vol. 13 Issue 9, p1388. 45p.
Autor:
Hämmerle SP; Novartis Pharma AG, Integrated Hospital Care Franchise, Basel, Switzerland., Mindeholm L, Launonen A, Kiese B, Loeffler R, Harfst E, Azria M, Arnold M, John MR
Publikováno v:
Bone [Bone] 2012 Apr; Vol. 50 (4), pp. 965-73. Date of Electronic Publication: 2012 Jan 25.